184 related articles for article (PubMed ID: 17030195)
1. A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data.
Poon TC; Wong N; Lai PB; Rattray M; Johnson PJ; Sung JJ
Gastroenterology; 2006 Oct; 131(4):1262-70. PubMed ID: 17030195
[TBL] [Abstract][Full Text] [Related]
2. Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.
Steinemann D; Skawran B; Becker T; Tauscher M; Weigmann A; Wingen L; Tauscher S; Hinrichsen T; Hertz S; Flemming P; Flik J; Wiese B; Kreipe H; Lichter P; Schlegelberger B; Wilkens L
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1283-91. PubMed ID: 16979954
[TBL] [Abstract][Full Text] [Related]
3. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome.
Katoh H; Shibata T; Kokubu A; Ojima H; Loukopoulos P; Kanai Y; Kosuge T; Fukayama M; Kondo T; Sakamoto M; Hosoda F; Ohki M; Imoto I; Inazawa J; Hirohashi S
J Hepatol; 2005 Nov; 43(5):863-74. PubMed ID: 16139920
[TBL] [Abstract][Full Text] [Related]
4. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization.
Guan XY; Fang Y; Sham JS; Kwong DL; Zhang Y; Liang Q; Li H; Zhou H; Trent JM
Genes Chromosomes Cancer; 2000 Oct; 29(2):110-6. PubMed ID: 10959090
[TBL] [Abstract][Full Text] [Related]
5. Clonal relationship of tumor nodules in hepatocellular carcinoma: a hierarchical clustering analysis of comparative genomic hybridization data.
Wong QW; Wong N; Lai PB; To KF; Wong N
Hum Pathol; 2005 Aug; 36(8):893-8. PubMed ID: 16112006
[TBL] [Abstract][Full Text] [Related]
6. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
[TBL] [Abstract][Full Text] [Related]
7. High-resolution mapping of copy number aberrations and identification of target genes in hepatocellular carcinoma.
Midorikawa Y; Tang W; Sugiyama Y
Biosci Trends; 2007 Aug; 1(1):26-32. PubMed ID: 20103863
[TBL] [Abstract][Full Text] [Related]
8. Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma.
Huang J; Sheng HH; Shen T; Hu YJ; Xiao HS; Zhang Q; Zhang QH; Han ZG
FEBS Lett; 2006 Jun; 580(15):3571-81. PubMed ID: 16750200
[TBL] [Abstract][Full Text] [Related]
9. Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma.
Midorikawa Y; Tsutsumi S; Nishimura K; Kamimura N; Kano M; Sakamoto H; Makuuchi M; Aburatani H
Cancer Res; 2004 Oct; 64(20):7263-70. PubMed ID: 15492245
[TBL] [Abstract][Full Text] [Related]
10. Comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) in the diagnosis of hepatocellular carcinoma.
Wilkens L; Bredt M; Flemming P; Mengel M; Becker T; Klempnauer J; Kreipe H
J Hepatobiliary Pancreat Surg; 2002; 9(3):304-11. PubMed ID: 12353141
[TBL] [Abstract][Full Text] [Related]
11. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.
Wong N; Lai P; Lee SW; Fan S; Pang E; Liew CT; Sheng Z; Lau JW; Johnson PJ
Am J Pathol; 1999 Jan; 154(1):37-43. PubMed ID: 9916916
[TBL] [Abstract][Full Text] [Related]
12. Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data.
Jiang F; Desper R; Papadimitriou CH; Schäffer AA; Kallioniemi OP; Richter J; Schraml P; Sauter G; Mihatsch MJ; Moch H
Cancer Res; 2000 Nov; 60(22):6503-9. PubMed ID: 11103820
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic alterations in liver cell tumors as detected by comparative genomic hybridization.
Terracciano L; Tornillo L
Pathologica; 2003 Apr; 95(2):71-82. PubMed ID: 12768875
[TBL] [Abstract][Full Text] [Related]
14. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array.
Park SJ; Jeong SY; Kim HJ
Cancer Genet Cytogenet; 2006 Apr; 166(1):56-64. PubMed ID: 16616112
[TBL] [Abstract][Full Text] [Related]
15. Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma.
Tanaka Y; Kanai F; Tada M; Tateishi R; Sanada M; Nannya Y; Ohta M; Asaoka Y; Seto M; Shiina S; Yoshida H; Kawabe T; Yokosuka O; Ogawa S; Omata M
J Hepatol; 2008 Nov; 49(5):746-57. PubMed ID: 18752864
[TBL] [Abstract][Full Text] [Related]
16. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
Mas VR; Fisher RA; Archer KJ; Yanek KC; Williams B; Dumur CI; Maluf DG
Transplantation; 2007 Apr; 83(7):973-81. PubMed ID: 17460570
[TBL] [Abstract][Full Text] [Related]
17. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma.
Miao X; Liu G; Xu X; Xie C; Sun F; Yang Y; Zhang T; Hua S; Fan W; Li Q; Huang S; Wang Q; Liu G; Zhong D
Cancer Genet Cytogenet; 2008 Oct; 186(1):25-32. PubMed ID: 18786439
[TBL] [Abstract][Full Text] [Related]
18. A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study.
Chochi Y; Kawauchi S; Nakao M; Furuya T; Hashimoto K; Oga A; Oka M; Sasaki K
J Pathol; 2009 Apr; 217(5):677-84. PubMed ID: 19097070
[TBL] [Abstract][Full Text] [Related]
19. High-dimensional biology to comprehend hepatocellular carcinoma.
Vivekanandan P; Singh OV
Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
[TBL] [Abstract][Full Text] [Related]
20. Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures.
Braconi C; Meng F; Swenson E; Khrapenko L; Huang N; Patel T
Cancer; 2009 Aug; 115(16):3738-48. PubMed ID: 19514085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
